Goldman Sachs Maintains Buy on Clarivate, Lowers Price Target to $20
Goldman Sachs maintains Clarivate (NYSE:CLVT) with a Buy and lowers the price target from $23 to $20.
Morgan Stanley Maintains Overweight on Clarivate, Lowers Price Target to $19
Morgan Stanley maintains Clarivate (NYSE:CLVT) with a Overweight and lowers the price target from $20 to $19.
78 Biggest Movers From Yesterday
Gainers
Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday.
32 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Bon Natural Life Limited (NASDAQ: BON) climbed 24.2% to $4.11 following FY21 results. Bon Natural Life reported FY21 earnings of $0.68 per share on sales of $25.5 million.
